Dr. Reddy's Labs Files Routine 6-K Disclosure
Ticker: RDY · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, routine-disclosure, foreign-private-issuer
Related Tickers: RDY
TL;DR
DRL filed a 6-K, just a routine check-in, no big news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 20, 2024, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, is submitting its report under the 1934 Act and will file its annual reports under cover of Form 20-F. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' compliance with SEC reporting requirements for foreign private issuers, ensuring transparency for investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain material non-public information that would typically impact stock price.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Filer of the Form 6-K
- 0001575872-24-001016 (filing_id) — Accession Number for the filing
- 20240920 (date) — Filing date
- Hyderabad, India (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Ltd. for routine disclosures.
What is the filing date of this report?
The filing date of this report is September 20, 2024.
Under which SEC form will Dr. Reddy's Laboratories Ltd. file its annual reports?
Dr. Reddy's Laboratories Ltd. will file its annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India.
Does this filing indicate any specific financial results or operational updates?
No, this Form 6-K filing serves as a routine disclosure and does not contain specific financial results or operational updates.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-20 12:07:22
Filing Documents
- drr0671_6k.htm (6-K) — 13KB
- drr0671_ex99-1.htm (EX-99.1) — 6KB
- drr0671_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0671_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-001016.txt ( ) — 35KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 20, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3